Literature DB >> 2916179

The incidence of intra-abdominal surgery in acquired immunodeficiency syndrome: a statistical review of 904 patients.

R D LaRaja1, R E Rothenberg, J W Odom, S C Mueller.   

Abstract

This communication concerns the incidence of intra-abdominal surgery in 904 patients with acquired immunodeficiency syndrome who were admitted to the Cabrini Medical Center during a 3-year period from January 1985 to January 1988. It was found that 36, or 4.2%, of the patients underwent surgery, including 12 cholecystectomies, 7 splenectomies, 7 appendectomies, 6 laparotomies, and 6 other operations for miscellaneous conditions. It was pointed out that the high incidence of inflammatory involvement of the gallbladder, appendix, and intestines in AIDS patients was in all probability due to the nature of the blood supply to these organs. All receive blood from terminal arteries or vessels with few anastomoses, and therefore when vasculitis ensues it is often followed by gangrene or ulceration of mucosal surfaces. Surgical intervention was deemed advantageous for those patients with splenomegaly and accompanying pancytopenia, acute appendicitis, and lesions of the gastrointestinal tract, but not for those with cholecystitis. The high postoperative mortality rate, 22.2%, was attributed primarily to the immunodeficient state of the patients rather than to complications of their surgery.

Entities:  

Mesh:

Year:  1989        PMID: 2916179

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  13 in total

1.  Acquired immune deficiency syndrome (AIDS). Indications for abdominal surgery, pathology, and outcome.

Authors:  S E Wilson; G Robinson; R A Williams; B E Stabile; L Cone; I J Sarfeh; D R Miller; E Passaro
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

2.  CD4 Count is Still a Valid Indicator of Outcome in HIV-Infected Patients Undergoing Major Abdominal Surgery in the Era of Highly Active Antiretroviral Therapy.

Authors:  A Chichom-Mefire; M Azabji-Kenfack; J Atashili
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

3.  Clinical Profile of Surgical Diseases with Emergence of New Problems in HIV+ Individuals.

Authors:  Tejaswini Vallabha; Mandar Dhamangaonkar; Vikram Sindgikar; Ravindra Nidoni; Harshavardhan Biradar; Aniketan Kv; Ramakant Baloorkar
Journal:  Indian J Surg       Date:  2016-01-25       Impact factor: 0.656

4.  Mycobacterium avium-intracellulare and acute abdominal pain.

Authors:  E M Boyle; K Stephens; T H Pohlman
Journal:  West J Med       Date:  1994-10

5.  Unusual cases of acute cholecystitis and cholangitis: Tokyo Guidelines.

Authors:  Hideki Yasuda; Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Koichi Hirata; Yasutoshi Kimura; Keita Wada; Fumihiko Miura; Masahiko Hirota; Toshihiko Mayumi; Masahiro Yoshida; Masato Nagino; Yuichi Yamashita; Serafin C Hilvano; Sun-Whe Kim
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

6.  Appendicitis in HIV-infected patients during the era of highly active antiretroviral therapy.

Authors:  N Crum-Cianflone; J Weekes; M Bavaro
Journal:  HIV Med       Date:  2008-07       Impact factor: 3.180

7.  Complications of laparoscopic cholecystectomy in HIV and AIDS patients.

Authors:  B J Carroll; R J Rosenthal; E H Phillips; H Bonet
Journal:  Surg Endosc       Date:  1995-08       Impact factor: 4.584

Review 8.  Major liver resection for non-Hodgkin's lymphoma in an HIV-positive patient: report of a case.

Authors:  A Picciocchi; R Coppola; F Pallavicini; M E Riccioni; S Ciletti; L M Marino-Cosentino; G Marasca; L Ortona
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

9.  Surgery during the COVID-19 pandemic.

Authors:  Hytham K S Hamid
Journal:  Lancet       Date:  2020-11-07       Impact factor: 79.321

10.  Anti-infective treatment in HIV-infected patients during perioperative period.

Authors:  Baochi Liu; Lei Zhang; Ruizhang Guo; Jinsong Su; Lei Li; Yanhui Si
Journal:  AIDS Res Ther       Date:  2012-11-27       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.